PODXL Human shRNA Plasmid Kit (Locus ID 5420)
CAT#: TG310316
PODXL - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (2)
PODXL mouse monoclonal antibody, clone OTI2C6 (formerly 2C6)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | PODXL Human shRNA Plasmid Kit (Locus ID 5420) |
Locus ID | 5420 |
UniProt ID | O00592 |
Synonyms | gp135; Gp200; PC; PCLP; PCLP-1; PDX; PODXL1 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | PODXL - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5420). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001018111, NM_005397, NM_005397.1, NM_005397.2, NM_005397.3, NM_001018111.1, NM_001018111.2, BC093730, BC093730.1, BC042466, BC112035, BC143318, NM_001018111.3, NM_005397.4 |
Summary | This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2
,San, IV;Prost, G;Williams, JA;Moss, SE;Nuber, UA;,
Biochem. Biophys. Res. Commun.
,PubMed ID 27470587
[PODXL]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...